Just like Vaccines have nothing to do with CytoDyn
Post# of 148153
The company itself isn’t involved and neither is the drug.
Any investor that bothers to read these boards also read about 2-4 more and believe that they got enough of both sides.
This is a clean board and I would like for it to stay that way.
Rebranding was named toward the end of the screenshot for a reason.
Before that is hold uplifted and trials starting + financing and inflection point.
Those are the things relevant to PRO140 / Leronlimab